ARCHIVES

NCI advisors approve recompetition of $62 million phase II contracts program.

This article is from The Cancer Letter archive.

Vol. 30 No. 44 | November 19, 2004

Download PDF Visit The Full Archive

Related Articles

NCI Advisory Group, Other Cancer Meetings

November 26, 1976

Bristol-Myers, IVAX submit Competing Application for Paclitaxel Use In KS

April 18, 1997

NCI Cooperative Group, Cancer Center Trials Listed

January 30, 2009

Advocacy Group Urges FDA to Sift Through Avastin Glioblastoma Data—Agency Accepts

June 14, 2013

“Withheld” News Release On QRA Policies Released

November 11, 1983

Chemical Distribution To Grantees Delayed while HEW Considers Charging For It

June 22, 1979